Restraining type I IFNs and type I ISGs from expression has been considered as a common mechanism for cancer cells to escape from immune surveillance.[43] We therefore propose that suppression of these genes by KDM5C might, at least partially, account for its oncogenic role in ERα‐positive breast cancers. This evidence concerns the gene ESR1 and breast carcinoma.